# A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants With Persistent Atrial Fibrillation

Study · id `cardio:ct-nct07523750` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07523750](<https://clinicaltrials.gov/study/NCT07523750>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07523750

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 566 participants.

## Technical summary

Registry record NCT07523750. Randomized; no masking; primary purpose treatment. Start 2026-04-02 (actual); primary completion 2028-05-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 566 participants (planned count; ClinicalTrials.gov record NCT07523750, source copy `cardio:ctgov-nct07523750-2026-11-03`, retrieved 2026-11-18)
- Started: 2026-04-02 (actual) (ClinicalTrials.gov record NCT07523750, source copy `cardio:ctgov-nct07523750-2026-11-03`, retrieved 2026-11-18)
- Primary completion: 2028-05-31 (anticipated) (ClinicalTrials.gov record NCT07523750, source copy `cardio:ctgov-nct07523750-2026-11-03`, retrieved 2026-11-18)
- Completion: 2028-05-31 (anticipated) (ClinicalTrials.gov record NCT07523750, source copy `cardio:ctgov-nct07523750-2026-11-03`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT07523750, source copy `cardio:ctgov-nct07523750-2026-11-03`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07523750-2026-11-03`, retrieved 2026-11-18)

## The registry's words

- Brief title: A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants With Persistent Atrial Fibrillation
- Acronym: PERSIGMA RCT
- Condition: Atrial Fibrillation
- Intervention (Device): VARIPULSE Catheter
- Intervention (Device): FARAWAVE Catheter
- Lead sponsor: Biosense Webster, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Biosense Webster, Inc. (`cardio:org-biosense-webster-inc`)

## Provenance

Content hash: 5b328c1a2c8974855cbe9ae8d0c29248dbca63d44882a0c858186e6d7b364428
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
